Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.
about
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritiPain management for rheumatoid arthritis and cardiovascular or renal comorbidityManagement of cardiovascular complications in systemic lupus erythematosus.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentCardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role.Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular diseaseHydroxychloroquine as a glucose lowering drug.Synergistic interaction between metformin and sulfonylureas on diclofenac-induced antinociception measured using the formalin test in rats.The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition.Inflammation and hypertension in rheumatoid arthritisRationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.Cardiovascular inflammation is reduced with methotrexate in diabetes.Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study.Simvastatin reduces leucocyte- and platelet-endothelial cell interaction in murine antigen-induced arthritis in vivo.Control of hyperglycemia in male mice by leflunomide: mechanisms of action.Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter CohortOmega-3 PUFA vs. NSAIDs for Preventing Cardiac InflammationRepurposing existing drugs for cardiovascular risk management: a focus on methotrexate
P2860
Q24235194-EB5644EE-DFCF-47B2-886C-539856346A24Q24235971-9B46AA52-ECA7-464E-BF41-AD9001CB80D8Q33730536-AA20FDE2-9E75-4FF2-B060-586BB16B3C60Q33943374-C2B305E5-AFA0-41DC-B919-23F8FD91707DQ34167653-C0DF4ED6-E328-4875-871C-76628E2C65D7Q34389286-01E5C9B2-667C-4F00-AA84-CFFBEF0F3F4AQ34444895-B7036CEE-31DB-4E42-B036-2FA60CC5FD01Q34459100-4F2F7041-7EE9-4242-8525-764CB0B9825CQ35519392-66C3BCA2-7C44-4A86-ACBF-6884930D2095Q37247791-DA254B38-8654-44F3-ADE9-9343087DAF6DQ37261219-D05555DA-79C4-4CC1-8E55-08DE1A9F3AAAQ37281848-B386E186-093E-4139-9C38-3648432D9934Q37466366-0966CB8A-6335-447B-8D5E-A9D97CEF1679Q38026796-3509B55F-E6AC-4C3A-9F3C-CE87BAC50E9DQ38902200-F21C9DFC-E5EE-4E94-90F3-60BFB2034431Q41718646-A0BD108A-E8F3-445B-BF38-A6800AB4C149Q51140338-B296C2A3-502E-4DDD-9746-A133894274A3Q52678340-0FC5178B-45D4-46DA-B5CB-D2B9EF3EC206Q57658287-75EEE70C-782A-43AE-A684-A3487BB2F623Q58571957-19572F68-D1E1-4BAC-8D00-2ABA4114FDB6Q59135667-2B5BBE46-F358-4313-BA00-127ECF5760F2
P2860
Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drugs Used in the Treatment of ...... d Cardiovascular Risk Factors.
@en
Drugs Used in the Treatment of ...... d Cardiovascular Risk Factors.
@nl
type
label
Drugs Used in the Treatment of ...... d Cardiovascular Risk Factors.
@en
Drugs Used in the Treatment of ...... d Cardiovascular Risk Factors.
@nl
prefLabel
Drugs Used in the Treatment of ...... d Cardiovascular Risk Factors.
@en
Drugs Used in the Treatment of ...... d Cardiovascular Risk Factors.
@nl
P2093
P2860
P1476
Drugs Used in the Treatment of ...... d Cardiovascular Risk Factors.
@en
P2093
Annette Oeser
C Michael Stein
Cecilia P Chung
Young Hee Rho
P2860
P356
10.1111/J.1753-5174.2009.00019.X
P577
2009-06-01T00:00:00Z